Journal of Medicinal Chemistry
Brief Article
(
2) Hoyer, D.; Hannon, J. P.; Martin, G. R. Molecular,
G.; Spedding, M.; Simig, G. Phenylpiperazinyl-butyl)oxindoles as
selective 5-HT(7) receptor antagonists. J. Med. Chem. 2008, 51, 2522−
2532.
(20) Volk, B.; Gacsalyi, I.; Pallagi, K.; Poszavacz, L.; Gyonos, I.;
Szabo, E.; Bako, T.; Spedding, M.; Simig, G.; Szenasi, G. Optimization
of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT7 receptor
antagonist activity. J. Med. Chem. 2011, 54, 6657−6669.
(21) Volk, B.; Simig, G. New one-pot synthesis of 3-alkyl- and 3-(ω-
hydroxyalkyl)oxindoles from isatins. Eur. J. Org. Chem. 2003, 3991−
3996.
pharmacological and functional diversity of 5-HT receptors.
Pharmacol., Biochem. Behav. 2002, 71, 533−554.
(
Vanhoenacker, P. Role of the 5-HT7 receptor in the central nervous
system: from current status to future perspectives. Mol. Neurobiol.
3) Matthys, A.; Haegeman, G.; Van Craenenbroeck, K.;
2
(
011, 43, 228−253.
4) Cassano, G. B.; Jori, M. C. Efficacy and safety of amisulpride 50
mg versus paroxetine 20 mg in major depression: a randomized,
double-blind, parallel group study. Int. Clin. Psychopharmacol. 2002, 17,
2
(
7−32.
(22) Paterson, L. M.; Kornum, B. R.; Nutt, D. J.; Pike, V. W.;
Knudsen, G. M. 5-HT radioligands for human brain imaging with PET
and SPECT. Med. Res. Rev. 2013, 33, 54−111.
(23) Lovell, P. J.; Bromidge, S. M.; Dabbs, S.; Duckworth, D. M.;
Forbes, I. T.; Jennings, A. J.; King, F. D.; Middlemiss, D. N.; Rahman,
S. K.; Saunders, D. V.; Collin, L. L.; Hagan, J. J.; Riley, G. J.; Thomas,
D. R. A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-
methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-
5) Lecrubier, Y.; Boyer, P.; Turjanski, S.; Rein, W. Amisulpride
versus imipramine and placebo in dysthymia and major depression.
Amisulpride Study Group. J. Affect. Disord. 1997, 43, 95−103.
(
H. Y.; Roth, B. L. Amisulpride is a potent 5-HT7 antagonist: relevance
for antidepressant actions in vivo. Psychopharmacology (Berlin) 2009,
2
(
Effects of lurasidone in behavioral models of depression. Role of the 5-
HT(7) receptor subtype. Neuropharmacology 2013, 70, 211−217.
(
Kristensen, J. L. (11)C-Labeling and preliminary evaluation of
vortioxetine as a PET radioligand. Bioorg. Med. Chem. Lett. 2014, 24,
2
(
6) Abbas, A. I.; Hedlund, P. B.; Huang, X. P.; Tran, T. B.; Meltzer,
05, 119−128.
2
(
69970). J. Med. Chem. 2000, 43, 342−345.
7) Cates, L. N.; Roberts, A. J.; Huitron-Resendiz, S.; Hedlund, P. B.
24) Romero, G.; Pujol, M.; Pauwels, P. J. Reanalysis of constitutively
active rat and human 5-HT7(a) receptors in HEK-293F cells
demonstrates lack of silent properties for reported neutral antagonists.
Naunym-Schmiedeberg’s Arch. Pharmacol. 2006, 374, 31−39.
8) Andersen, V. L.; Hansen, H. D.; Herth, M. M.; Knudsen, G. M.;
(25) Suter, T. M.; Chesterfield, A. K.; Bao, C.; Schaus, J. M.;
Krushinski, J. H.; Statnick, M. A.; Felder, C. C. Pharmacological
characterization of the cannabinoid CB1 receptor PET ligand
ortholog, [H-3]MePPEP. Eur. J. Pharmacol. 2010, 649, 44−50.
408−2411.
9) Zhang, M. R.; Haradahira, T.; Maeda, J.; Okauchi, T.; Kida, T.;
Obayashi, S.; Suzuki, K.; Suhara, T. Synthesis and preliminary PET
study of the 5-HT7 receptor antagonist [C-11]DR4446. J. Labelled
Compd. Radiopharm. 2002, 45, 857−866.
(26) Terry, G.; Liow, J. S.; Chernet, E.; Zoghbi, S. S.; Phebus, L.;
Felder, C. C.; Tauscher, J.; Schaus, J. M.; Pike, V. W.; Halldin, C.;
Innis, R. B. Positron emission tomography imaging using an inverse
agonist radioligand to assess cannabinoid CB(1) receptors in rodents.
Neuroimage 2008, 41, 690−698.
(
10) Andries, J.; Lemoine, L.; Mouchel-Blaisot, A.; Tang, S.;
Verdurand, M.; Le Bars, D.; Zimmer, L.; Billard, T. Looking for a 5-
HT7 radiotracer for positron emission tomography. Bioorg. Med.
Chem. Lett. 2010, 20, 3730−3733.
(27) Terry, G. E.; Liow, J. S.; Chernet, E.; Zoghbi, S. S.; Phebus, L.;
Lerner, A.; Felder, C. C.; Tauscher, J.; Schaus, J. M.; Pike, V. W.;
Halldin, C.; Innis, R. B. Evaluation of an inverse agonist with high
affinity for the CB1 receptor, [C-11]MePPEP, in rodents and humans.
Neuroimage 2008, 41, T197−T197.
(
11) Herth, M. M.; Hansen, H. D.; Ettrup, A.; Dyssegaard, A.; Lehel,
S.; Kristensen, J.; Knudsen, G. M. Synthesis and evaluation of [C-
1]Cimbi-806 as a potential PET ligand for 5-HT7 receptor imaging.
Bioorg. Med. Chem. 2012, 20, 4574−4581.
12) Herth, M. M.; Volk, B.; Pallagi, K.; Bech, L. K.; Antoni, F. A.;
1
(
Knudsen, G. M.; Kristensen, J. L. Synthesis and in vitro evaluation of
oxindole derivatives as potential radioligands for 5-HT7 receptor
imaging with PET. ACS Chem. Neurosci. 2012, 3, 1002−1007.
(
13) Hansen, H. D.; Herth, M. M.; Ettrup, A.; Andersen, V. L.; Lehel,
S.; Dyssegaard, A.; Kristensen, J. L.; Knudsen, G. M. Radiosynthesis
and in vivo evaluation of novel radioligands for PET imaging of
cerebral 5-HT7 receptors. J. Nucl. Med. 2014, 55, 640−646.
(
14) Lacivita, E.; Niso, M.; Hansen, H. D.; Di Pilato, P.; Herth, M.
M.; Lehel, S.; Ettrup, A.; Montenegro, L.; Perrone, R.; Berardi, F.;
Colabufo, N. A.; Leopoldo, M.; Knudsen, G. M. Design, synthesis,
radiolabeling and in vivo evaluation of potential positron emission
tomography (PET) radioligands for brain imaging of the 5-HT7
receptor. Bioorg. Med. Chem. 2014, 22, 1736−1750.
(
15) Zimmer, L.; Billard, T. Molecular imaging of the serotonin 5-
HT7 receptors: from autoradiography to positron emission tomog-
raphy. Rev. Neurosci. 2014, 25, 357−365.
(
16) Lemoine, L.; Andries, J.; Le Bars, D.; Billard, T.; Zimmer, L.
Comparison of 4 radiolabeled antagonists for serotonin 5-HT7
receptor neuroimaging: toward the first PET radiotracer. J. Nucl.
Med. 2011, 52, 1811−1818.
(
17) Hansen, H. C.; Andersen, V. L.; Lehelc, S.; Magnussen, J. H.;
Dyssegaard, A.; Stroth, N.; Kristensen, J. L.; Knudsen, G. M.; Herth,
M. M. Labeling and preliminary in vivo evaluation of the 5-HT7
receptor selective agonist [11C]E-55888. Bioorg. Med. Chem. Lett.
2
(
015, DOI: 10.1016/j.bmcl.2015.03.039.
18) Andersen, V. L.; Herth, M. M.; Lehel, S.; Knudsen, G. M.;
Kristensen, J. L. Palladium-mediated conversion of para-amino-
arylboronic esters into para-aminoaryl-C-11-methanes. Tetrahedron
Lett. 2013, 54, 213−216.
(
19) Volk, B.; Barkoczy, J.; Hegedus, E.; Udvari, S.; Gacsalyi, I.;
Mezei, T.; Pallagi, K.; Kompagne, H.; Levay, G.; Egyed, A.; Harsing, L.
3
636
J. Med. Chem. 2015, 58, 3631−3636